Atlas Trials

Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD

Clinical trial NCT02652598 · UNKNOWN

Trial details

NCT number
NCT02652598
Sponsor
Sheppard Pratt Health System
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Brain Injuries, TraumaticNeurocognitive DisordersBrain Injuries
Start date
2015-11-01
Primary completion
2020-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.